Maintaining a Robust Pipeline
Licensing and M&A are critical to maintaining a robust pipeline. Competition for early- and late-stage compounds is extensive; those who are slow to identify and move on opportunities are likely to lose them. Exceptional pharmaceutical business development teams address critical strategic needs by aligning goals with deal opportunities, navigating negotiation challenges, and establishing clear protocols to manage relationships and create lucrative partnerships.
Accelerate Business Development Strategies
Through deep expertise across therapy areas, the Collective Acumen team developed novel approaches in medical market research, integrating risk assessment, pricing elements, commercialization planning and rapid analysis.
Objective Process
Our process ensures that complex opportunities are well-evaluated and aligned with portfolio and strategic priorities. In a highly dynamic regulatory environment with increasing globalization, CA provides critical support at all phases of the business development process.
- Technology & Market Assessments
- Product & Franchise Plans
- Clinical & Lifecycle Strategy Development
- Enhanced Market Research
- Market Sizing & Sector Growth Analysis
- Management Decision Support
- Internal Diligence
- Forecast Analogue Scenarios